adx-097
·Code: ADX-097
adx-097: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Q32 Bio Inc. (QTTB) | Phase 2 |
Clinical Trials (1)
A Phase 2 Study to Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Clinical Activity of ADX-097 Administered Subcutaneously in Male and Female Participants Aged 18 Years or Older With IgAN, LN, or C3G
Frequently asked questions
Who is developing adx-097?
adx-097 is being developed by Q32 Bio Inc..
How many clinical trials involve adx-097?
BioSniper tracks 1 clinical trial involving adx-097.
Get deeper analysis on adx-097
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis